AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$37.22
arrow_upward
+1.58%(+0.58) 1 天
10月21日, GMT-4 13:17:07 · USD
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 AGIO 生成关键数据洞见…
开盘价
US$36.62
最高价
US$37.41
最低价
US$36.46
市值
22.22亿
平均成交量
116.57万
成交量
25.07万
52 周最高价
US$45.99
52 周最低价
US$22.24
每股收益
-US$7.01
Beta 版
0.63
流通股数
5970.20万
员工人数
540
开盘价
US$36.62
最高价
US$37.41
最低价
US$36.46
市值
22.22亿
平均成交量
116.57万
成交量
25.07万
52 周最高价
US$45.99
52 周最低价
US$22.24
每股收益
-US$7.01
Beta 版
0.63
流通股数
5970.20万
员工人数
540
新闻报道
来自网络来源和新闻合作伙伴
Yahoo Finance
·
17小时前
Did Priority Review Just Shift Agios Pharmaceuticals' (AGIO) Investment Narrative?
Stock Traders Daily
·
22小时前
(AGIO) Price Dynamics and Execution-Aware Positioning
资料
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Agios Pharmaceuticals Inc简介